cilostazol has been researched along with Amyloid Angiopathy, Cerebral in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, M | 1 |
| Saito, S | 1 |
| Inoue, T | 1 |
| Satoh-Asahara, N | 1 |
| Ihara, M | 2 |
| Yakushiji, Y | 1 |
| Kawamoto, K | 1 |
| Uchihashi, K | 1 |
| Aoki, S | 1 |
| Nagaishi, Y | 1 |
| Suzuyama, K | 1 |
| Tsugitomi, Y | 1 |
| Hara, H | 1 |
1 review available for cilostazol and Amyloid Angiopathy, Cerebral
| Article | Year |
|---|---|
Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Ac | 2020 |
1 other study available for cilostazol and Amyloid Angiopathy, Cerebral
| Article | Year |
|---|---|
Low-Dose Phosphodiesterase III Inhibitor Reduces the Vascular Amyloid Burden in Amyloid-β Protein Precursor Transgenic Mice.
Topics: Amyloid beta-Peptides; Animals; Blood Vessels; Brain; Cerebral Amyloid Angiopathy; Cilostazol; Femal | 2020 |